Latest posts tagged with #FSGS on Bluesky
Great paper from @carafuentes-neph.bsky.social !!
Tackling #nephroticsyndrome from many angles, better treatments are on the horizon!
Congrats Gabriel & team!!!!
#FSGS #pediatricnephrology #NephSky #SkyNeph #humangenetics
@science.org
www.science.org/doi/10.1126/...
In this interview, Dr. Howard Trachtman discusses targeted therapies for FSGS, including BI 764198, a TRPC6 inhibitor that was the subject of a recent study published by The Lancet. #kidneydisease #FSGS #nephrology #nephsky buff.ly/CvQ7u8J
ACTN4 p.Ile150Met Causes #FSGS With Validation in #Primary #Fibroblasts and Immortalized Podocytes
https://doi.org/10.1016/j.ekir.2025.11.030
#KIRResearchLetter
💥 Die Dissertation von FSGS-Alumna Jana Maria Weiß ist bei de Gruyter Brill erschienen.
🔗 Mehr Informationen auf unserer Website. Link im Profil!
#publikation #neuerscheinung #fsgs #paulcelan
❄️ Nach einem produktiven und erfolgreichen Wintersemester verabschieden wir uns nun in die Semesterpause. Wir wünschen euch gute Erholung und freuen uns darauf, euch im Sommersemester 2026 wieder an der #FSGS begrüßen zu dürfen.
#fsgs #literatur #semesterferien #fuberlin
Proud today to share our latest work showing in vivo evidence that podocyte-derived ET-1 activating GEC ETA drives glomerular injury in FSGS. Congrats Liping Yu & @ubonge.bsky.social and big thanks to all co-authors for this tremendous team effort. #FSGS #nephrology #daehnlab @kidneyint.bsky.social
Podocyte derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis
doi.org/10.1016/j.kint.2026.01.014
#NephSky #MedSky #OpenAccess #FSGS
Editorial: Special Report
ICD-10 codes for APOL1-mediated kidney disease
doi.org/10.1016/j.kint.2025.09.025
#NephSky #MedSky #chronickidneydisease #FSGS #APOL1 @wakeforestmed.bsky.social
Im morgigen Mittagsforum der #FSGS stellt Luca Lil Wirth ihre Tätigkeit an der Alice Salomon Hochschule als Koordinatorin eines Drittmittelprojekts vor.
🔗 Zum Programm: bit.ly/fsgsmittagsg...
#Mittagsforum #Wintersemester202526 #fuberlin
🗞️ CATCH UP with kidney news, including an FDA delay for sparsentan in #FSGS, a new #CKD guideline from two government agencies, and more. #nephsky #nephrology #kidneytransplant #kidneydisease www.docwirenews.com/post/kidney-...
Great collaboration with the @kidneyomicsamps.bsky.social lab! Thank you Matt for bringing back #MEFV for me, the disease that ignited my interest for #humangenetics when I was still a student! And now a risk factor for #FSGS! When things come together..
www.kidney-international.org/article/S008...
Pediatric results from DUPLEX show sparsentan is well tolerated and achieves superior, sustained proteinuria reduction versus the maximum IRB dose in FSGS. #KidneyWk #nephsky #Nephrology #FSGS #Pediatrics www.docwirenews.com/post/sparsen...
Dimerix Successfully Completes Recruitment for Phase 3 ACTION3 Trial of DMX-200 #Australia #Melbourne #FSGS #Dimerix #DMX-200
Great collaboration with Florian Buerger, Friedhelm Hildebrandt, Jim Fawcett, @kidneyomicsamps.bsky.social, Markus Rinschen and many others. Huge thanks to all of our students who contributed so much to this work.
#raredisease #nephrology #nephtwitter #medtwitter #kidney #fsgs
Commentary
Mineralocorticoid receptor blockade quiesces parietal epithelial cell activation
Mallipattu S.
doi.org/10.1016/j.kint.2025.08.016
Original article: doi.org/10.1016/j.kint.2025.07.037
#MedSky #NephSky #ckd #chronickidneydisease #fsgs
@stonybrookmedicine.bsky.social
My nephew is sick and the family is going through it right now. I don’t have a lot of followers but I’m hoping a couple of you see this and share. It would be greatly appreciated! ❤️
#GoFundMe #FSGS
gofund.me/2de4a5146
Interesting read on the protective p.N264k (M1) #APOL1 variant and #kidneydisease and #FSGS.
More to come soon on M1…. Stay tuned :)
@bhallaresearch.bsky.social
@gbadegesinlab.bsky.social @kidneyomicsamps.bsky.social
It was an honor for us to host Dr. Sandeep Mallipattu in #Seattle for Nephrology Grand Rounds! Take a look at his fantastic talk, "Treating FSGS: Something Old, Something New, Something Still in Motion." #kidney #nephrology #FSGS @uwmedicine.bsky.social #nephsky #meded
youtu.be/Nu8VZHuVTdY
Hilar variant of focal segmental glomerulosclerosis, with segmental sclerosis at the vascular pole with hyalinosis and adhesion (Jones silver stain)
bit.ly/49P5wQP (FREE)
#FSGS #renalpath
#MassSpectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis #MCD #FSGS
#VisualAbstract by Sophia Ambruso
www.kireports.org/article/S2468-0249(25)00...
Joel Topf @kidneyboy.bsky.social spoke with Jai Radhakrishnan at #KidneyWk about his late-breaking research poster describing a new analysis of data from the DUPLEX trial of sparsentan in #FSGS. #nephsky #nephrology www.docwirenews.com/post/sparsen...
Thank you @asnpublications.bsky.social !!!
This is a true honor, and a sprinkle of good luck!
#FSGS #rFSGS #raredisease #APOL1 #CAKUT #NephSky #SkyNeph
@asnkidney.bsky.social
@isgd.bsky.social
Prevalence, Resource Utilization, and Economic Impact of Kidney Function and Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) ca. 2025 from @juancarlosqvelez.bsky.social
#Nephpearls #FSGS #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41222995/
Cellular variant of focal segmental glomerulosclerosis, with endocapillary hypercellularity with foam cells and mononuclear cells (top; Jones silver stain)"
bit.ly/4nNJdy2 (FREE)
#renalpath #FSGS
Tip lesion with localized sclerotic lesion only involving the proximal tubular pole of the glomerulus (Jones silver stain).
FREE The tip lesion variant of focal segmental glomerulosclerosis (FSGS) is associated with nephrotic syndrome and usually responds to steroid therapy. This #FSGS variant has the lowest risk for progression to kidney failure.
bit.ly/47tgF8l #RenalPath
Renalys Pharma Finalizes Agreement with Japan's PMDA for Clinical Trials of Sparsentan #Japan #Tokyo #Sparsentan #Renalys_Pharma #FSGS
Highly recommended contribution from Detlef Bockenhauer et al: a modern view of the genetic landscape of kidney diseases!
#genetics #CAKUT #FSGS #APOL1 #NephSky #SkyNeph #Medsky #raredisease #RKD
@melaniechan.bsky.social @oalavijeh.bsky.social @horiastanescu.bsky.social @dannygale.bsky.social
Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis.
doi.org/10.1016/j.kint.2025.07.037
#OpenAccess #NephSky #MedSky #CKD #FSGS #chronickidneydisease @parcc-inserm.bsky.social @rwth.bsky.social
